Home    Company News    Honors | Alioth won the "2023 Top 20 Innovation and Entrepreneurship in Pudong New Area"

Honors | Alioth won the "2023 Top 20 Innovation and Entrepreneurship in Pudong New Area"



Recently, Shanghai Pudong New Area People's Government held the "Pudong New Area Economic outstanding contribution Enterprises Commendation" activity. Alioth Biotech (Shanghai) Co., Ltd. won the honor of "2023 Top 20 Innovation and Entrepreneurship in Pudong New Area" with its technological innovation strength and outstanding progress in the field of biomedicine industry in the past year. Jia Qijun, founder and CEO of Alioth, was invited to attend the award ceremony.

The award of "2023 Top 20 Innovation and Entrepreneurship in Pudong New Area" is a high recognition from Pudong New Area for the achievements made by Alioth on the path of innovative development.



Established in Lingang New Area of Pudong New District, Alioth has been focusing on the development and dedicated to providing pharmaceutical companies with high-quality separation and purification solutions that comply with domestic and international regulations.


In order to accelerate the breakthrough of filter membrane "stuck neck" technology, Alioth has set up filter membrane research and development center and filter product research and development center in Boston, USA and Shanghai Lingang, China, and formed a research and development team led by life science scientists and materials science scientists to realize innovation and breakthrough of pharmaceutical filter membrane and filter products based on pharmaceutical customer applications. At present, our products include deep filter, cartridge filter, bag filter, dish filter, hollow fiber, filter hardware solutions and laboratory filter products.


Since its establishment, Alioth has made remarkable achievements: The filter products have been recognized and product access by many well-known biopharmaceutical enterprises at home and abroad, and have been applied in the production of a number of commercial drugs; At the same time, it has also received nearly 200 million yuan of financing from investment institutions such as Junilian Capital, Matrix Partners and Astrazeneca Zhongjin Medical Industry Fund to support the company's continuous research and development and industrialization of filter membrane materials and related products.


The numerous achievements and progress made by Alioth cannot be achieved without the strong support and careful guidance of leaders at all levels such as Pudong New Area, Lingang Management Committee, Lingang Group and industrial zone companies in various aspects of industrial policy support, talent policy and enterprise services.


In the future, Alioth will continue to take root in the hot land of Lingang New Area of Pudong New District, deeply cultivate the field of pharmaceutical filtration technology, commit to breaking through the underlying technology of new filter membrane materials, constantly improve its technological innovation strength, develop more stable and excellent products, and provide a strong guarantee for the supply chain safety and drug production quality of pharmaceutical enterprises. To contribute to the vigorous development of Pudong's biomedical industry.